An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis

Active, not recruitingOBSERVATIONAL
Enrollment

537

Participants

Timeline

Start Date

December 16, 2016

Primary Completion Date

December 10, 2026

Study Completion Date

March 11, 2027

Conditions
Ulcerative Colitis
Trial Locations (63)

Unknown

Murrieta

Rialto

Ventura

Coral Gables

Fort Myers

Lake Worth

Lauderdale Lakes

Miami

Tampa

Suwanee

Chicago

Sylvania

Pittsburgh

Houston

San Antonio

Lansdowne Town Center

Salzburg

Sankt Poelten Noe

Vienna

New Westminster

Vancouver

Oshawa

Ottawa

Pilsen

Clermont-Ferrand

Clichy

Créteil

Grenoble

Montpellier

Nice

Pierre-Bénite

Saint-Priest-en-Jarez

Strasbourg

Berlin

Dessau Roblau

Halle

Hamburg

Heidelberg

Kiel

Leipzig

Ludwigshafen

Lyneburg

München

Saarbrücken

Athens

Heraklion

Ioannina

Thessaloniki

Busan

Gyeonggi-do

Seongnam-si

Seoul

A Coruña

Barcelona

Córdoba

Fuenlabrada

Huelva

Madrid

Majadahonda

San Sebastián de los Reyes

Valencia

Vigo

Zaragoza

Sponsors
All Listed Sponsors
lead

Janssen Biotech, Inc.

INDUSTRY

NCT02808780 - An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis | Biotech Hunter | Biotech Hunter